TORONTO, March 15, 2016 -- Nevada Zinc Corporation (the “Corporation”) (TSX-V:NZN) is pleased to announce that it intends to complete a non-brokered private placement financing of up to 5,000,000 common shares in the capital stock of the Corporation (“Shares”) at a price of $0.30 per Share for gross proceeds of up to $1,500,000 (the “Offering”).
The net proceeds of the Offering will be used for exploration, metallurgical test work and general working capital purposes. The Shares issued pursuant to the Offering will be subject to a statutory four month and one day hold period. The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the TSX Venture Exchange and applicable securities regulatory authorities. The Corporation intends to close the Offering on or about March 31, 2016.
An 8% finder’s fee is payable in cash or Shares (at a deemed value of $0.30 per Share) to eligible finders, along with finder’s warrants (“Finder’s Warrants”) equal to 8% of the number of Shares placed by an eligible finder pursuant to the Offering. Each Finder’s Warrant shall entitle the holder to acquire one Share at a price of $0.30 per Share for a period of 24 months following the closing date of the Offering.
About Nevada Zinc
The Corporation is a discovery driven, early-stage mineral exploration company with a proven management team focused on identifying unique opportunities in mineral exploration that can provide significant value to its shareholders. The Corporation’s existing projects are located in Nevada and Yukon.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information contact: Nevada Zinc Corporation 141 Adelaide St. West, Suite 1660 Toronto, Ontario M5H 3L5 Tel: 416.504.8821 Bruce Durham, President and CEO [email protected] www.nevadazinc.com


Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 



